PMID- 30023064 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220321 IS - 2050-6406 (Print) IS - 2050-6414 (Electronic) IS - 2050-6406 (Linking) VI - 6 IP - 6 DP - 2018 Jul TI - The distribution of HLA DQ2 and DQ8 haplotypes and their association with health indicators in a general Danish population. PG - 866-878 LID - 10.1177/2050640618765506 [doi] AB - BACKGROUND: Human leukocyte antigen (HLA) DQ2 and DQ8 are important risk factors for some autoimmune diseases such as celiac disease (CD), but their possible role in other diseases and health conditions is not fully explored. OBJECTIVES: The objective of this article is to examine the distribution of HLA DQ2 and HLA DQ8 in an adult general population, and their association with health indicators (diseases, symptoms and biomarkers). METHODS: In this cross-sectional, population-based study, 2293 individuals were screened for HLA DQ2 and DQ8; CD-associated alleles (DQA*0201*03*05/DQB*02*0301/0304*0302/0305) and DQB1*02 homozygosity were determined for screen-positive participants. The National Patient Registry provided diagnosis information. RESULTS: A total of 47.7% (1093/2293) individuals were positive for DQ2 and/or DQ8: 31.2% (716/2293) only DQ2, 11.9% (273/2293) only DQ8, 4.1% (93/2293) both DQ2 and DQ8. Among nine individuals diagnosed with CD, 89.9% (8/9) had DQ2.5cis, 22.2% (2/9) DQ8 and 22.2% (2/9) DQ2.2 (two both DQ2 and DQ8). HLA DQ2.5 was associated with higher thyroid-stimulating hormone levels, while DQ2/DQ8-positive participants had significantly lower prevalence of irritable bowel syndrome (IBS). DQ2/DQ8 were strongly associated with CD, but no other registry-based diagnoses. CONCLUSION: In this general Danish population, 47.7% were HLA DQ2/DQ8 positive and thus potentially at risk for CD. All individuals with CD were DQ2/DQ8 positive; the majority DQ2.5. Surprisingly, DQ2/DQ8-positivity was associated with lower IBS prevalence. FAU - Karhus, Line Lund AU - Karhus LL AD - Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark. AD - Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. FAU - Thuesen, Betina H AU - Thuesen BH AD - Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark. AD - Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. FAU - Skaaby, Tea AU - Skaaby T AD - Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark. AD - Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. FAU - Rumessen, Juri J AU - Rumessen JJ AD - Q&D-Research Unit and Department of Gastroenterology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. FAU - Linneberg, Allan AU - Linneberg A AD - Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark. AD - Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. AD - Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. AD - Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark. LA - eng PT - Journal Article DEP - 20180308 PL - England TA - United European Gastroenterol J JT - United European gastroenterology journal JID - 101606807 PMC - PMC6047278 OTO - NOTNLM OT - Celiac disease OT - HLA DQ2 OT - HLA DQ8 OT - epidemiology EDAT- 2018/07/20 06:00 MHDA- 2018/07/20 06:01 PMCR- 2018/07/01 CRDT- 2018/07/20 06:00 PHST- 2017/12/29 00:00 [received] PHST- 2018/02/21 00:00 [accepted] PHST- 2018/07/20 06:00 [entrez] PHST- 2018/07/20 06:00 [pubmed] PHST- 2018/07/20 06:01 [medline] PHST- 2018/07/01 00:00 [pmc-release] AID - 10.1177_2050640618765506 [pii] AID - 10.1177/2050640618765506 [doi] PST - ppublish SO - United European Gastroenterol J. 2018 Jul;6(6):866-878. doi: 10.1177/2050640618765506. Epub 2018 Mar 8.